Stay updated on DS-8201a in HER2 NSCLC Clinical Trial

Sign up to get notified when there's something new on the DS-8201a in HER2 NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DS-8201a in HER2 NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Core study details, eligibility criteria, outcomes, and participating locations appear unchanged; observed differences are limited to minor formatting and UI adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:24:40.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    35 days ago
    Change Detected
    Summary
    Added a government-operating-status notice and a new version tag (v3.2.0); removed the old version tag (v3.1.0).
    Difference
    3%
    Check dated 2025-10-06T05:53:59.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Page version updated from v3.0.2 to v3.1.0; no other substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:10:26.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2 and Back to Top was removed; overall changes are minor and do not affect core content or user-facing information.
    Difference
    0.2%
    Check dated 2025-09-14T19:56:05.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T16:53:45.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of specific facility names and locations, as well as detailed references to studies involving Trastuzumab Deruxtecan. Notably, the previous mentions of Trastuzumab and certain location details have been removed.
    Difference
    8%
    Check dated 2025-08-31T12:06:36.000Z thumbnail image

Stay in the know with updates to DS-8201a in HER2 NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DS-8201a in HER2 NSCLC Clinical Trial page.